The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303

[1]  Kenji Suzuki,et al.  Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303 , 2021, Annals of Surgical Oncology.

[2]  G. Guaitoli,et al.  Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy. , 2021, Clinical nutrition ESPEN.

[3]  H. Miyata,et al.  Thoracic and cardiovascular surgeries in Japan during 2018 , 2020, General Thoracic and Cardiovascular Surgery.

[4]  Taichi Matsubara,et al.  Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer , 2020, Annals of Surgical Oncology.

[5]  E. Miyaoka,et al.  Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study. , 2020, Lung cancer.

[6]  M. Tsuboi,et al.  Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. , 2020, The New England journal of medicine.

[7]  D. Nguyen,et al.  Lobectomy Versus Stereotactic Body Radiotherapy In Healthy Octogenarians With Stage I Lung Cancer. , 2020, The Annals of thoracic surgery.

[8]  M. Nishihira,et al.  Inflammatory Risk Factors for Early Recurrence of Non-Small Cell Lung Cancer Within One Year Following Curative Resection , 2020, World Journal of Surgery.

[9]  Jun Liang,et al.  Systemic Inflammation-immune Status Predicts Survival in Stage III-N2 Non-small Cell Lung Cancer. , 2019, The Annals of thoracic surgery.

[10]  M. Tomita,et al.  The Prognostic Values of a Novel Preoperative Inflammation-Based Score in Japanese Patients With Non-Small Cell Lung Cancer , 2019, World journal of oncology.

[11]  Y. Maehara,et al.  A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase. , 2019, Journal of thoracic disease.

[12]  M. Tsuboi,et al.  Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan , 2018, Japanese journal of clinical oncology.

[13]  O. Ljungqvist,et al.  Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS) , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  David R. Jones,et al.  A systematic review and meta‐analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer , 2019, The Journal of thoracic and cardiovascular surgery.

[15]  Jun Wu,et al.  Effect of C‐reactive protein/albumin ratio on prognosis in advanced non–small‐cell lung cancer , 2018, Asia-Pacific journal of clinical oncology.

[16]  S. Gallus,et al.  Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants , 2018, Scientific Reports.

[17]  J. Nakajima,et al.  Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  M. Okada,et al.  A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303 , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  Y. Maehara,et al.  Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study. , 2018, Interactive cardiovascular and thoracic surgery.

[20]  S. Okada,et al.  Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer , 2017, Japanese journal of clinical oncology.

[21]  D. Su,et al.  The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer , 2016, Oncotarget.

[22]  T. Nagayasu,et al.  Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients , 2017, Surgery Today.

[23]  H. Saji,et al.  Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303) , 2016, General Thoracic and Cardiovascular Surgery.

[24]  T. Nagayasu,et al.  Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  K. Koike,et al.  The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.

[26]  D. Talwar,et al.  An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study , 2011, British Journal of Cancer.

[27]  E. Miyaoka,et al.  Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[29]  K. Yasuda,et al.  Thoracic and Cardiovascular Surgery in Japan during 2000 : Annual Report by The Japanese Association for Thoracic Surgery , 2002 .

[30]  S. Worrall.  TNM Classification of Malignant Tumours. , 2000 .